Most lately, it has been recognized that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in related areas as classical opioid receptors, it binds to a big selection of endogenous opioids. Not like most opioid receptors, this receptor functions as a scavenger and won't activate a next messeng